Three phase 3 trials presented at the 2026 ESMO Congress looked closely at swallowing, daily functioning and blood counts in ...

A national survey study of about 200,000 adults, published in Supportive Care in Cancer, found that people caring for someone ...

C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean ...

Dr. Morana Vojnic answers common questions about brain cancer, including diagnosis, tumor types, treatment effects, ...

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.

Four phase 3 trials at ESMO 2026 brought news for people with small cell, EGFR, MET and KRAS G12C lung cancer, plus a caution ...

Longer follow-up presented at the 2026 ESMO Congress showed that four already-approved treatments for early breast cancer, ...

For people with lung or pancreatic cancer driven by changes in the KRAS gene, research presented at the 2026 European Society ...

Five phase 3 trials presented at ESMO 2026 showed new options in small cell lung, bladder, prostate, KRAS G12C lung and ...

Two phase 3 trials at ESMO 2026 brought new options for advanced endometrial cancer, and final results for Verzenio after another CDK4/6 drug showed a survival difference that was not statistically ...

C, discusses why he built the MyUrova app and how men with prostate, bladder, kidney or testicular cancer can prepare for ...

A clinical trial will test zanubrutinib plus sonrotoclax as a fixed-duration, chemotherapy-free treatment for hairy cell ...